KLUS Pharma to attend AACR Annual Meeting 2024

KLUS Pharma will attend the AACR Annual Meeting held in San Diego, CA from April 5-10, 2024. KLUS Pharma is the US subsidiary of Kelun-Biotech, a mid-sized innovative biopharma company based in Chengdu, China. Kelun-Biotech is advancing a broad pipeline of small molecules, monoclonal antibodies, and antibody drug conjugates (ADCs) for the treatment of cancer, autoimmune, metabolic, and cardiovascular diseases. With over ten clinical-stage assets and dozens of promising preclinical candidates, we are aiming to become a leader in the oncology field and deliver safer, more efficacious, and affordable medicines to cancer patients in China and worldwide. To achieve our mission, we welcome the opportunity to learn from and work with other like-minded scientists and colleagues working at the forefront of both preclinical and clinical cancer research.